Personalizing Circumpapillary Retinal Nerve Fiber Layer Thickness Norms for Glaucoma
Personalizing Circumpapillary Retinal Nerve Fiber Layer Thickness Norms for Glaucoma
批准号:
10728042
负责人:
Mengyu Wang
金额:
$55.7万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-30 至 2025-08-31
关键词:
AblationAgeAge related macular degenerationAnatomyArtificial IntelligenceAttentionBlindnessBlood VesselsCaringClinicalComplexCustomDataData SetDevicesDiabetic RetinopathyDiagnosisDiameterEarExclusionEyeFundusGenderGermanyGlaucomaImageIndividualIndividual AdjustmentInner Limiting MembraneLasersLassoLengthLinear RegressionsLocationManualsMapsMassachusettsMeasurementMeasuresModelingMonitorMotivationNeural Network SimulationOphthalmoscopyOptic DiskOptical Coherence TomographyPatientsPerformancePopulation StudyPrincipal Component AnalysisPublic HealthRetinaScanningSpecialistStructureSurfaceTechnologyTestingThickTorsionTrainingValidationVariantVisual Fieldsclinical careclinically relevantconvolutional neural networkdeep learning modeldesignfeature extractionfovea centralisfunctional lossfundus imaginghigh dimensionalityimprovedinnovationnovelretinal imagingretinal nerve fiber layersuccess
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Motivation and Hypotheses: The circumpapillary RNFL thickness (cpRNFLT) measured by circle scan is
routinely used for glaucoma diagnosis. Precise cpRNFLT norms are important for assessing cpRNFLT
abnormalities, while current optical coherence tomography (OCT) devices used in glaucoma care only adjust
the cpRNFLT norms for age. Prior studies attempted to adjust cpRNFLT norms for retinal anatomy either by
manually delineated features such as blood vessel location and disc-fovea angle or standard clinical metrics
such as scan diameter and axial length, while manual feature extraction is laborious and standard clinical
metrics are insufficient to represent the complex retinal anatomical variation. We hypothesize that we can
leverage artificial intelligence (AI) modeling to (1) improve cpRNFLT norms by automatically adjusting for
retinal anatomy encoded by retinal imaging data, which can be then used to (2) improve glaucoma diagnosis.
Aim 1: Developing AI-based models to personalize cpRNFLT norms with individual retinal anatomy.
Healthy subject data from the Leipzig population-based study will be used to develop Lasso linear regression
and deep learning models to adjust pointwise cpRNFLT norms for retinal anatomy represented by inner limiting
membrane (ILM) maps and scanning laser ophthalmoscopy (SLO) fundus images. 60%, 20% and 20% of the
entire dataset will be used for training, validation and testing, respectively. The cpRNFLT norm accuracy will be
measured by mean absolute error and R2. For the Lasso model, we will apply principal component analysis
followed by uniform manifold approximation and projection to extract retinal anatomical features from the ILM
map and SLO fundus image. For the deep learning model, we will use both the pre-trained deep learning
model ResNet-50 and a custom designed convolutional neural network ignoring missing imaging values.
Aim 2: Clinical relevance validation for the personalized cpRNFLT norms based on individual retinal
anatomy. Glaucoma patient data from Massachusetts Eye and Ear will be used to demonstrate the clinical
relevance of our personalized cpRNFLT norms with Lasso linear regression and deep learning models. The
pointwise cpRNFLT deviation percentiles will be used to predict accompanying VFs. Mean absolute error and
R2 on the testing subset will be used to evaluate model performance. Paired t-test will be performed to
compare if using cpRNFLT deviation percentiles normalized by our personalized cpRNFLT norms can better
predict VFs compared with by the standard cpRNFLT norms only adjusting for age, gender and scan diameter.
For the deep learning model, a 1D convolutional neural network enhanced by attention units will be developed.
Main Deliverables and Public Health Impacts: This project will construct personalized cpRNFLT norms by
automatically adjusting for individual retinal anatomy using retinal imaging data with cutting edge AI
technology. The success of this project may have a great impact to improve clinical care for glaucoma patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Relationship between Glaucoma and the Three-Dimensional Optic Nerve Head Related Structure
-
批准号:10332738
-
项目类别:
-
资助金额:$24.72万
-
财政年份:2021
-
负责人:Mengyu Wang
-
依托单位:
Relationship between Glaucoma and the Three-Dimensional Optic Nerve Head Related Structure
-
批准号:10594994
-
项目类别:
-
资助金额:$24.72万
-
财政年份:2021
-
负责人:Mengyu Wang
-
依托单位:
Relationship between Glaucoma and the Three-Dimensional Optic Nerve Head Related Structure
-
批准号:10316448
-
项目类别:
-
资助金额:$24.72万
-
财政年份:2021
-
负责人:Mengyu Wang
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: